Molluscum contagiosum
Conditions
Interventions
SB206 and vehicle are applied.
Sponsors
Tsubouchi Ichiro
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese adult males aged 20 to 40 years at the time of obtaining written informed consent 2. Subjects with a body mass index (BMI) of 18.5 to 25.0 at screening 3. Subjects who are considered by the investigator or subinvestigator as acceptable for inclusion in the study as judged from the results of observation and examination upon screening and hospitalization 4. Subjects who received full explanations regarding the objective of the study, details of the study and the study drug and provided voluntary written informed consent
Exclusion criteria
Exclusion criteria: 1. Subjects with a history of drug allergy 2. Subjects with a history of food allergy 3. Subjects with a history of contact dermatitis, such as adhesive tape dermatitis, or mechanical urticaria 4. Subjects considered ineligible for the study by the investigator or subinvestigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin irritation | — |
Contacts
Public ContactClinical Trials Information Desk
Sato Pharmaceutical Co., Ltd.
Outcome results
None listed